
Christina Bradley
Examiner (ID: 2253, Phone: (571)272-9044 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 1470 |
| Issued Applications | 827 |
| Pending Applications | 184 |
| Abandoned Applications | 516 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18596074
[patent_doc_number] => 20230270865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => LOW-DOSE PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/012496
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012496
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/012496 | LOW-DOSE PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF | Jun 29, 2021 | Pending |
Array
(
[id] => 18947055
[patent_doc_number] => 11890328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Fibroin-derived protein composition
[patent_app_type] => utility
[patent_app_number] => 17/360674
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 14527
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360674 | Fibroin-derived protein composition | Jun 27, 2021 | Issued |
Array
(
[id] => 17312897
[patent_doc_number] => 20210401945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => STABLE SUSTAINED RELEASE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/359202
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359202 | Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same | Jun 24, 2021 | Issued |
Array
(
[id] => 20413030
[patent_doc_number] => 12496292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => PSMA binding ligand-linker conjugates and methods for using
[patent_app_type] => utility
[patent_app_number] => 17/358726
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 37
[patent_no_of_words] => 17174
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358726 | PSMA binding ligand-linker conjugates and methods for using | Jun 24, 2021 | Issued |
Array
(
[id] => 17398002
[patent_doc_number] => 20220040092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => Ready to use injectable formulations of Micafungin Sodium
[patent_app_type] => utility
[patent_app_number] => 17/355876
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/355876 | Ready to use injectable formulations of Micafungin Sodium | Jun 22, 2021 | Abandoned |
Array
(
[id] => 17398002
[patent_doc_number] => 20220040092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => Ready to use injectable formulations of Micafungin Sodium
[patent_app_type] => utility
[patent_app_number] => 17/355876
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/355876 | Ready to use injectable formulations of Micafungin Sodium | Jun 22, 2021 | Abandoned |
Array
(
[id] => 17520512
[patent_doc_number] => 20220106361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/355022
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/355022 | Macrocyclic compounds and methods of use thereof | Jun 21, 2021 | Issued |
Array
(
[id] => 19563546
[patent_doc_number] => 12138297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Collagen hydrolysate for use with skin disorders and intestinal disorders
[patent_app_type] => utility
[patent_app_number] => 17/350280
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 3869
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350280 | Collagen hydrolysate for use with skin disorders and intestinal disorders | Jun 16, 2021 | Issued |
Array
(
[id] => 17334685
[patent_doc_number] => 20220001016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => CONJUGATES FOR TARGETING AND CLEARING AGGREGATES
[patent_app_type] => utility
[patent_app_number] => 17/350675
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350675 | Conjugates for targeting and clearing aggregates | Jun 16, 2021 | Issued |
Array
(
[id] => 18116365
[patent_doc_number] => 11547737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Compositions and methods for treating virus infection
[patent_app_type] => utility
[patent_app_number] => 17/350170
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 11807
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350170 | Compositions and methods for treating virus infection | Jun 16, 2021 | Issued |
Array
(
[id] => 18861893
[patent_doc_number] => 20230416328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung Injury
[patent_app_type] => utility
[patent_app_number] => 18/009590
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009590
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009590 | C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung Injury | Jun 10, 2021 | Pending |
Array
(
[id] => 18536077
[patent_doc_number] => 20230241164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => C-Type Natriuretic Peptides and Methods Thereof in Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 18/009596
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009596 | C-Type Natriuretic Peptides and Methods Thereof in Treating Cancer | Jun 10, 2021 | Pending |
Array
(
[id] => 18861893
[patent_doc_number] => 20230416328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung Injury
[patent_app_type] => utility
[patent_app_number] => 18/009590
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009590
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009590 | C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung Injury | Jun 10, 2021 | Pending |
Array
(
[id] => 18861893
[patent_doc_number] => 20230416328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung Injury
[patent_app_type] => utility
[patent_app_number] => 18/009590
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009590
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009590 | C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung Injury | Jun 10, 2021 | Pending |
Array
(
[id] => 18597216
[patent_doc_number] => 20230272010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => ANTIBACTERIAL SYNTHETIC-BIOINFORMATIC NATURAL PRODUCTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/008006
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008006
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008006 | ANTIBACTERIAL SYNTHETIC-BIOINFORMATIC NATURAL PRODUCTS AND USES THEREOF | Jun 3, 2021 | Pending |
Array
(
[id] => 17412774
[patent_doc_number] => 20220047678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Combination Therapy for Treatment of Liver Disease
[patent_app_type] => utility
[patent_app_number] => 17/337576
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337576 | Combination Therapy for Treatment of Liver Disease | Jun 2, 2021 | Abandoned |
Array
(
[id] => 17905512
[patent_doc_number] => 11459356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Neuronal nicotinic acetylcholine receptor-targeting polypeptide and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/329191
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 2109
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329191
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/329191 | Neuronal nicotinic acetylcholine receptor-targeting polypeptide and use thereof | May 24, 2021 | Issued |
Array
(
[id] => 18215286
[patent_doc_number] => 11590199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Use of an ABC transporter peptide inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/324053
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 21
[patent_no_of_words] => 6069
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324053 | Use of an ABC transporter peptide inhibitor | May 17, 2021 | Issued |
Array
(
[id] => 19479435
[patent_doc_number] => 20240327477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF TDP-43 PROTEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/997142
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997142 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TDP-43 PROTEINOPATHIES | Apr 26, 2021 | Pending |
Array
(
[id] => 17399572
[patent_doc_number] => 20220041662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => CELL PENETRATING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/238994
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/238994 | CELL PENETRATING PEPTIDES | Apr 22, 2021 | Pending |